Allspring Global Investments Holdings LLC Buys 3,122,716 Shares of Amrize Ltd $AMRZ

Allspring Global Investments Holdings LLC grew its stake in Amrize Ltd (NYSE:AMRZ) by 247.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,386,926 shares of the company’s stock after purchasing an additional 3,122,716 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Amrize were worth $212,449,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. BNP Paribas Financial Markets bought a new stake in shares of Amrize in the 2nd quarter worth approximately $59,000. Groupe la Francaise bought a new position in Amrize during the second quarter valued at $60,000. Allianz SE purchased a new stake in Amrize in the second quarter worth $80,000. Osaic Holdings Inc. bought a new stake in shares of Amrize in the second quarter valued at $90,000. Finally, Credit Industriel ET Commercial bought a new stake in shares of Amrize in the second quarter valued at $109,000.

Amrize Price Performance

Shares of AMRZ opened at $54.96 on Wednesday. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $56.76. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.85 and a current ratio of 1.45. The stock has a 50 day moving average price of $51.85. The stock has a market capitalization of $30.40 billion and a price-to-earnings ratio of 29.87.

Amrize (NYSE:AMRZ) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The firm had revenue of $3.68 billion for the quarter, compared to analysts’ expectations of $3.49 billion. Amrize’s revenue for the quarter was up 6.6% compared to the same quarter last year.

Insider Buying and Selling at Amrize

In related news, CTO Roald Brouwer acquired 4,000 shares of Amrize stock in a transaction dated Friday, October 31st. The shares were purchased at an average cost of $51.77 per share, with a total value of $207,080.00. Following the completion of the purchase, the chief technology officer owned 9,000 shares of the company’s stock, valued at $465,930. This represents a 80.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jaime Hill acquired 4,000 shares of the firm’s stock in a transaction dated Tuesday, November 4th. The stock was bought at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the acquisition, the insider owned 18,101 shares of the company’s stock, valued at approximately $917,539.69. This trade represents a 28.37% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have acquired 65,000 shares of company stock valued at $3,399,720.

Wall Street Analysts Forecast Growth

AMRZ has been the subject of several research reports. Oppenheimer began coverage on Amrize in a research note on Tuesday, September 9th. They set an “outperform” rating and a $62.00 price target for the company. Kepler Capital Markets upgraded shares of Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Deutsche Bank Aktiengesellschaft set a $59.00 price target on shares of Amrize in a research note on Monday, December 8th. UBS Group raised their price objective on shares of Amrize from $52.00 to $53.00 and gave the stock a “neutral” rating in a report on Monday, November 3rd. Finally, Stephens assumed coverage on shares of Amrize in a report on Friday, November 14th. They set an “overweight” rating and a $60.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $60.00.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.